The centralized procurement bidding is still going on.

"We are now conducting the 28th bidding. This time the bid is for lung cancer drugs. Pharmaceutical companies that have registered, please follow me to Conference Room 5."

"Let's go!"

Li Shen looked at Oris and Barton with interest, then immediately stood up and called the other team members to walk out of the conference room and head to Conference Room 5.

"fuk!"

When Oris of Luohua saw Li Shen walk out, he couldn't help but swear.

But in the end, he had to stand up and walk out.

Although he was not optimistic about the result, Oris had to go.

There was still a little hope if he went, but if he didn't go, there would be no hope at all.

Anyone who was a normal person would know how to choose.

What's more, Oris must have come with a mission.

If this centralized procurement was completed too badly, he would not be able to explain to the head office.

Now the head office was in a state of panic.

Everyone was in danger!

Oris didn't want to touch this bad luck at this time.

If this centralized procurement failed, Oris might become the first target of the head office.

The end would definitely be miserable!

If... There is even a slight possibility that Oris does not want to put himself in such a situation.

Therefore, every centralized procurement here is a goal that he is determined to fight for.

Although Johnson & Johnson's Barton 743 is not in as big a predicament as Oris, Barton dare not take it lightly.

Because there has been a precedent of ibrutinib, Barton is still very worried that the ibrutinib incident will happen again.

Especially after the mass launch of 38 new drugs by Ali Pharmaceuticals, Barton is even more afraid that those drugs that overlap with these 38 drugs will follow in the footsteps of ibrutinib?

There is no way, this Ali Pharmaceutical is simply too unethical.

This is an original drug, and every drug has played a huge role from research to market launch.

And And the success rate is particularly low.

If one out of 10 drugs developed can be successfully launched on the market, that would be good.

With such a huge investment, how can you lower the price at will, and lower it so drastically

? Is this really appropriate?

Isn't it obvious that Ali Pharmaceuticals is killing one thousand enemies and losing eight hundred of its own?

This is the problem that Patton cannot understand the most.

However, it is okay to not understand.

The facts that should be faced must be faced.

Since Ali Pharmaceuticals has done this, Patton cannot sit idly by.

Because there is already a precedent of ibrutinib, Patton dare not take it lightly.

He does not want other drugs to follow in the footsteps of ibrutinib.

If something like this happens again, Patton can directly... Pack up and leave.

This is also the reason why Barton is so active in participating in the centralized procurement this time.

If it were in the past, Barton would have simply disdained these centralized procurements.

Johnson & Johnson has launched innovative drugs with particularly significant efficacy, and they will not have trouble selling them even if they are expensive.

Because the population of Longguo is too large, and there are many rich people.

More importantly, there are too few competitors.

And even if there are competitors, everyone tacitly sets the price at a comparable level.

So even if the price remains sky-high, sales have always been in short supply.

Therefore, there is no need to participate in centralized procurement to reduce one's wealth.

But after the appearance of Ali Pharmaceutical, this troublemaker, everything changed.

If they still don't seek change, then all they will face is destruction.

20 minutes later, the 28th round of centralized procurement negotiations ended.

This time, there were no surprises again. Ali Pharmaceutical's Bailiwei won again with a price of 3.8 yuan per tablet. In the 32nd round,

Ali Pharmaceutical took the field again.

There were no surprises, and it won again.

The 38th,

43rd, (to read exciting novels, go to Faloo Novel Network!) and 56th rounds, as long as Ali signed up for the rounds, he always beat Luohua and Johnson & Johnson.

Seeing that Li Shen had no bottom line to break through the price, Luohua's Oris and Johnson's Patton could only stare blankly.

In the end, this centralized procurement was successfully concluded.

It can be said that some people are happy and some are worried about this centralized procurement.[]

The happiest people are not the pharmaceutical companies, but the Medical Insurance Administration.

Moreover, the director of the Medical Insurance Administration is still proud of his wise decision to invite Ali Pharmaceuticals.

There is no other way. With the participation of Ali Pharmaceuticals this time, everyone's enthusiasm for bidding has increased a lot.

The most important thing is that there is Ali Pharmaceuticals, a shit stick.

Those foreign pharmaceutical companies that have always been high and mighty before have to bow their heads and participate in this centralized procurement.

Moreover, the price cuts are unprecedented. The price of this centralized procurement is much lower than the Medical Insurance Administration expected before.

Especially those innovative drugs that were previously high-priced.

These drugs generally did not participate in centralized procurement before. Even if these innovative drugs participated in centralized procurement, they still maintained a relatively high price.

This time it is different. With Ali Pharmaceuticals, a shit stick, the price is almost reduced to the cost price.

But even so, Ali Pharmaceuticals finally defeated Luohua and Johnson & Johnson and won a big victory.

Ali Pharmaceuticals registered 39 drugs, but all 39 drugs won the bid.

And these 39 drugs are all innovative drugs.

This time, Ali Pharmaceuticals has completely smashed the high-priced label that comes with innovative drugs.

And pressed it to the ground and rubbed it.

However, Li Shen was not very happy about Ali Pharmaceutical's great victory this time.

It can only be regarded as a sigh of relief and the completion of the task assigned by the big boss behind the scenes.

After all, the price of each drug participating in the centralized procurement is a fracture among fractures, and the profit is almost negligible.

To put it bluntly, this time it is almost a loss-making profit.

So for Li Shen, there is really nothing to be happy about.

Originally, Li Shen was going to wait until the next 38 drugs were launched on the market, make some money, and then change to a better office space.

But now, I am afraid that it cannot be realized for the time being.

However, Li Shen was not too discouraged.

Although there is no big office for the time being, he still feels that his life value has been realized and sublimated.

Before, Li Shen devoted himself to the research and development of innovative drugs, not just to make money in the future.

It was more for the anger in his heart.

Every time he saw people in his own country, they could only choose those very expensive innovative drugs, but they had no choice and were forced to accept high prices.

At that time, in addition to spitting on these innovative pharmaceutical companies that took advantage of the fire, Li Shen could only secretly hate that his country had been stagnant in innovative drugs.

In order to fight for a breath, Li Shen left the Fortune 500, ran to the suburbs, rented a shabby factory, and worked on research and development day and night.

But what Li Shen welcomed was not success, but betrayal, and he almost went bankrupt.

However, in the end, it can be said that there is always a way out.

The appearance of the big boss behind the scenes not only made Li Shen reborn, but also gave Li Shen the opportunity to breathe a sigh of relief.

So Li Shen has no complaints about the boss behind the scenes, as long as he is grateful

PS:Please give me flowers, evaluation votes, and a full approval.

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like